Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

76 trials with published results (28%)

Research Maturity

191 completed trials (70% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

5.1%

14 terminated out of 273 trials

Success Rate

93.2%

+6.6% vs benchmark

Late-Stage Pipeline

32%

86 trials in Phase 3/4

Results Transparency

40%

76 of 191 completed with results

Key Signals

76 with results93% success14 terminated

Data Visualizations

Phase Distribution

241Total
Not Applicable (96)
Early P 1 (2)
P 1 (18)
P 2 (39)
P 3 (34)
P 4 (52)

Trial Status

Completed191
Unknown34
Recruiting15
Terminated14
Not Yet Recruiting7
Active Not Recruiting6

Trial Success Rate

93.2%

Benchmark: 86.6%

Based on 191 completed trials

Clinical Trials (273)

Showing 20 of 20 trials
NCT05121493Not ApplicableWithdrawnPrimary

Study of Platelet Rich Plasma Drops to Moderate Clinically Significant Dry Eye

NCT06903611Phase 3Not Yet Recruiting

Phase III Study of Topical Fibrinogen-Depleted Human Platelet Lysate Compared to Placebo for Moderate to Severe Dry Eye

NCT05481450Not ApplicableCompleted

Efficacy and Safety Safety of Nutritears® in Adults With Dry Eye Syndrome

NCT07618364Not ApplicableRecruitingPrimary

The Effect of Rinsing on Ocular Inflammation and Symptoms in Patients With Dry Eye Disease

NCT06483750Not ApplicableCompleted

Preoperative iLux on Cataract Surgery Derived Dry Eye Disease Due to Meibomian Gland Dysfunction

NCT07588074Phase 4Completed

Tolerability Comparison of Flarex to Lotemax SM

NCT07415330Not ApplicableNot Yet Recruiting

Lacrima VR for Dry Eye Disease and Meibomian Gland Dysfunction

NCT06220474Not ApplicableRecruitingPrimary

Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD

NCT05784519Early Phase 1Active Not Recruiting

Therapeutic Effect of Stem Cell Eye Drops on Dry Eye Disease

NCT04730336Not ApplicableCompleted

Assessing the Impact of Tixel Treatment of Periorbital Wrinkles on Dry Eye Symptoms and Signs

NCT06089317Not ApplicableCompletedPrimary

Traditional Chinese Medicine Ultrasonic Atomization Treatment for Dry Eye Disease

NCT06388070Phase 3CompletedPrimary

To Evaluate the Efficacy and Safety of HUC3-053 in Patients With Dry Eye Syndrome

NCT07430137Not ApplicableNot Yet RecruitingPrimary

Blink Reminders and Meibomian Gland Loss in Digital Screen Users

NCT07412860Not ApplicableRecruitingPrimary

Clinical Investigation Between the Topical Administration of a Tear Substitute With Ancillary Medicinal Substance and Hyaluronic Acid 0.3% (FBV_01) vs Hyaluronic Acid 0.3% in Subjects in the Treatment From Moderate to Severe DED

NCT06004895Not ApplicableCompletedPrimary

Mechanisms of Light-based Therapies for Dry Eye Disease

NCT01684852CompletedPrimary

Non Interventional Study to Evaluate the Efficacy and Tolerability of Ectoin Containing Ophthalmic Solution

NCT06371300Not ApplicableRecruitingPrimary

Photobiomodulation With REd vs BluE Light (REBEL)

NCT06163989Not ApplicableRecruitingPrimary

Protecting the Eyes of Gamers With Lubricating Eyedrops

NCT03697876Phase 1CompletedPrimary

Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel

NCT05653921SuspendedPrimary

Prospective Study to Validate the Imaging Biomarker for NCP (R33)

Scroll to load more

Research Network

Activity Timeline